Koyama Motoi, Murata Akihiro, Sakamoto Yoshiyuki, Morohashi Hajime, Takahashi Seiji, Yoshida Eri, Hakamada Kenichi
Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Aomori, Japan,
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S422-8. doi: 10.1245/s10434-014-3573-1. Epub 2014 Feb 22.
Intersphincteric resection (ISR) is an alternative to abdominoperineal resection (APR) for super-low rectal cancer. The aim of this study was to evaluate the long-term curability after ISR over an average 6-year observational period, to compare the postoperative functional outcomes for ISR with those for low anterior resection (LAR), and to determine whether ISR is a function-preserving surgery.
Between 2000 and 2007, a total of 77 consecutive patients with low rectal cancer underwent curative ISR. The curability outcomes for ISR, LAR, and APR were compared. We evaluated the postoperative defecation functions, Wexner incontinence score (WIS), and defecation quality of life (QOL) for a between-groups comparison (ISR/LAR).
The 5-year survival rate after ISR was 76.4 %, and the outcome was better than for APR (APR 51.2 %, LAR 80.7 %). Local recurrence after ISR occurred in 7.8 % of patients (APR 12.1 %, LAR 11.7 %). The average daily frequency of defecation was 3.7 times for the ISR patients and 3.2 times for the LAR patients, indicating no significant difference between the groups. Moreover, there were no significant differences between the groups for defecation functions. The WIS was 8.1 for ISR and 4.9 for LAR, and the defecation QOL for ISR and LAR was not significantly different (modified fecal incontinence QOL score: ISR 34.3, LAR 26.5).
The long-term clinical and functional results suggest that ISR may be the optimal sphincter-preserving surgery for patients with lower rectal cancers who cannot be treated with a double-stapling technique.
对于超低位直肠癌,括约肌间切除术(ISR)是腹会阴联合切除术(APR)的一种替代术式。本研究旨在评估ISR术后平均6年观察期内的长期治愈率,比较ISR与低位前切除术(LAR)的术后功能结局,并确定ISR是否为保留功能的手术。
2000年至2007年期间,共有77例连续性低位直肠癌患者接受了根治性ISR。比较了ISR、LAR和APR的治愈结局。我们评估了术后排便功能、韦克斯纳失禁评分(WIS)以及排便生活质量(QOL),以进行组间比较(ISR/LAR)。
ISR术后5年生存率为76.4%,其结局优于APR(APR为51.2%,LAR为80.7%)。ISR术后局部复发率为7.8%的患者(APR为12.1%,LAR为11.7%)。ISR患者的平均每日排便次数为3.7次,LAR患者为3.2次,表明两组之间无显著差异。此外,两组之间的排便功能也无显著差异。ISR的WIS为8.1,LAR为4.9,ISR和LAR的排便QOL无显著差异(改良大便失禁QOL评分:ISR为34.3,LAR为26.5)。
长期临床和功能结果表明,对于无法采用双吻合器技术治疗的低位直肠癌患者,ISR可能是最佳的保留括约肌手术。